Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

1. Pawlyn, C.
2. Schjesvold, F.H.
3. Cairns, D.A.
4. Wei, L.J.
5. Davies, F.
6. Nadeem, O.
7. Abdulhaq, H.
8. Mateos, M.-V.
9. Laubach, J.
10. Weisel, K.
11. Ludwig, H.
12. Rajkumar, S.V.
13. Sonneveld, P.
14. Jackson, G.
15. Morgan, G.
16. Richardson, P.G.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/S41408-024-01109-4 GOOGLE SCHOLAR lock_openOpen access editor